IDO1 and neoplasm: For instance, IDO1 produced in APCs might increase peripheral tolerance to tumor-associated antigens (TAAs) in tumor-draining lymph nodes, maintaining the activity of TAA-expressing malignant cells (Zhang et al., 2018).